Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes
- 31 December 2003
- journal article
- clinical trial
- Published by Elsevier BV in Ophthalmology
- Vol. 110 (12), 2372-2383
- https://doi.org/10.1016/j.ophtha.2003.08.020
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- ANECORTAVE ACETATE AS MONOTHERAPY FOR THE TREATMENT OF SUBFOVEAL LESIONS IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION (AMD)Published by Ovid Technologies (Wolters Kluwer Health) ,2003
- PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2002
- Statins Have Biphasic Effects on AngiogenesisCirculation, 2002
- Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfinOphthalmology, 2001
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinAmerican Journal of Ophthalmology, 1999
- Angiostatic Activity of Steroids in the Chick Embryo CAM and Rabbit Cornea Models of NeovascularizationJournal of Ocular Pharmacology and Therapeutics, 1999
- AL-3789: a novel ophthalmic angiostatic steroidExpert Opinion on Investigational Drugs, 1997
- Subfoveal Neovascular Lesions in Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 1991
- Early Treatment Diabetic Retinopathy Study Design and Baseline Patient CharacteristicsOphthalmology, 1991
- Lens Opacities Classification System II (LOCS II)American Journal of Ophthalmology, 1989